“…The identification of CI in MS can be difficult as they may occur at both early and late stages of the disease and may be masked by more visible symptoms, such as fatigue, depression, and pain (Guimarães & Sá, ; Kraemer, Herold, Uekermann, Kis, Daum, et al ., ; Kraemer, Herold, Uekermann, Kis, Wiltfang, et al ., ). CI has a negative impact on a patient's quality of life and as well as their caregivers’ (Labiano‐Fontcuberta, Mitchell, Moreno‐García, & Benito‐León, ; Rao et al ., ). It is therefore important to detect these deficits at an earliest possible stage and to monitor progression frequently, which is particularly crucial for the development and application of remediation strategies (Amato, Zipoli, & Portaccio, ).…”